Riskpilot← Back to searchSign inGet full accessDukat Läkarkonsult AB
ABActiveOrg 5590553763Källsjövägen 40Hospital activities · NACE 8610Est. 20160 employees
Revenue 2025
SEK 691K
-42% vs 2024
EBITDA margin
81.8%
-40% vs 2024
Equity ratio
88.1%
Financial strength
Net profit 2025
SEK 441K
-44% vs 2024
| Revenue | SEK 691K | -42% |
| EBITDA | SEK 565K | -40% |
| Net profit | SEK 441K | -44% |
| Total assets | SEK 2,8M | -24% |
| Equity | SEK 2,5M | +11% |
| Employees | 0 | — |
Legal name
Dukat Läkarkonsult AB
Org number
5590553763
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
16 mars 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinska tjänster och konsultationer, läkarbemanning inom sluten och öppen vård, medicinsk vård samt annan därmed förenlig verksamhet. Bolaget ska äga och förvalta fastigheter och värdepapper.
Address
Källsjövägen 40
Email
jovanovic.le.dusan@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 468 | 784 | 826 | 1 191 | 691 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 349 | 587 | 602 | 939 | 565 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 349 | 587 | 602 | 939 | 565 |
| Net financials | — | −0 | 2 | 40 | −1 |
| Profit before tax | 349 | 736 | 604 | 978 | 564 |
| Tax | −73 | −161 | −133 | −193 | −123 |
| Net profit | 276 | 575 | 471 | 785 | 441 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 412 | 1 718 | 2 079 | 3 755 | 2 835 |
| Equity | 1 006 | 1 401 | 1 673 | 2 258 | 2 499 |
| Long-term debt | 0 | — | — | 1 000 | 0 |
| Short-term debt | 257 | 317 | 406 | 497 | 336 |
| Total debt | 257 | 317 | 406 | 1 497 | 336 |
EBITDA margin
81.8%
This company
15.8%
Market median
+418% vs market
20212025
Equity ratio
88.1%
This company
38.2%
Market median
+131% vs market
20212025
Return on equity
17.6%
This company
18.4%
Market median
+4% vs market
20212025
Net profit margin
63.9%
This company
8.1%
Market median
+689% vs market
20212025
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dukat Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Katarina Maria Vahlgren | Deputy Board Member | 0 companies |
| Dusan Jovanovic | Board of Directors | 0 companies |
| Zoran Jovkovic Hagert | Deputy Board Member | 0 companies |